Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by jojomarchon Dec 12, 2017 2:33pm

117 Views

Post# 27140365

Conditional Nod

LaserStock wrote about the " Conditional Nod " possibility not long ago . I think because the FDA has approved PHOTOFRIN and ALA in the past , it wouldn't be much of a stretch to give the Conditional Nod to TLD-1433 . It's like saying yes to a new and improved existing technology . TLT has good human results in the trial so they could get both the NOD and the Ph 2 approval basically at the same time .

GLTA

Bullboard Posts

NervGen: Are amazing human trial results leaking out?